Global Blood Therapeutics (GBT) PT Lowered to $69 at RBC Capital
Tweet
Share
E-mailGet Alerts GBT Hot Sheet
Price: $68.49 --0%
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
12 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
RBC Capital analyst Gregory Renza lowered the price target on Global Blood Therapeutics (NASDAQ: GBT) to $69.00 (from $75.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- NKT A/S (NKT:DC) PT Raised to DKK917 at JPMorgan
- NKT A/S (NKT:DC) PT Lowered to DKK916 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
